Meloxicam and diclofenac do not change VEGF and PDGF-AB serum levels of platelet-rich plasma
TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.47, sa.2, ss.570-576, 2017 (SCI-Expanded, Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 47 Sayı: 2
- Basım Tarihi: 2017
- Doi Numarası: 10.3906/sag-1602-60
- Dergi Adı: TURKISH JOURNAL OF MEDICAL SCIENCES
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.570-576
- Anahtar Kelimeler: Platelet-rich plasma, PDGF-AB, VEGF, nonsteroidal antiinflammatory drugs, NONSTEROIDAL ANTIINFLAMMATORY DRUGS, HUMAN TENDON CELLS, GROWTH-FACTORS, IN-VITRO, CLINICAL-APPLICATIONS, PROLIFERATION, INHIBITION, PRP
- Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
- Hacettepe Üniversitesi Adresli: Evet
Özet
Background/aim: Platelet-rich plasma (PRP) application has gained widespread interest for musculoskeletal injuries. Nonsteroidal antiinflammatory drugs are frequently used in sports medicine before and/or after PRP application. Our study seeks to determine whether serum levels of platelet-derived growth factor-AB (PDGF-AB) and vascular endothelial growth factor (VEGF) levels of PRP would be affected by nonsteroidal antiinflammatory drugs.